Search Result
Results for "
pegylated liposomes
" in MedChemExpress (MCE) Product Catalog:
41
Biochemical Assay Reagents
| Cat. No. |
상품명 |
Target |
연구분야 |
Chemical Structure |
-
- HY-126505
-
|
|
ADC Linker
|
Cancer
|
|
Mal-PEG4-NHS ester is a non-cleavable ADC linker which links Quantum dots (QDs) with PEGylated liposomes .
|
-
-
- HY-172723
-
|
|
Liposome
Transferrin Receptor
|
Neurological Disease
Cancer
|
|
DSPE-PEG2000-T7 is a PEGylated compound composed of DSPE and peptideT7. T7 (HAIYPRH) specifically binds to TfR. DSPE-PEG2000-T7 can be used to prepare T7-modified liposomes, where liposomes modified with both T7 and DA7R peptides can effectively co-deliver Doxorubicin (HY-15142A) and Vincristine (HY-N0488A) to gliomas. DSPE-PEG2000-T7 can also be used to prepare nanomodulators that mediate the co-delivery of tyrosine hydroxylase mRNA and interferon gene stimulator antagonists for synergistic intervention in Parkinson's disease .
|
-
-
- HY-W591424
-
|
mPEG2000-SC; mPEG2000-Succinimidyl ester
|
Biochemical Assay Reagents
MMP
|
Cancer
|
|
m-PEG2000-NHS ester (mPEG2000-SC) is a reagent with both cell adhesion inhibition and peptide conjugation functions. The NHS ester group of m-PEG2000-NHS ester forms stable amide bonds with primary amine-containing molecules (e.g., the N-terminus of MMP-2-cleavable octapeptide) to generate mPEG-peptide intermediates for liposome surface modification. When m-PEG2000-NHS ester is immobilized on a cystamine-modified gold surface, it can construct an in vitro model for cell adhesion kinetic studies, and higher PEG density and thicker layers correlate with lower cell adhesion rates. m-PEG2000-NHS ester can synthesize MMP-2-responsive PEGylated lipid conjugates to achieve MMP-triggered dePEGylation in the tumor microenvironment. m-PEG2000-NHS ester can be used in studies related to colon cancer and other conditions .
|
-
-
- HY-144012
-
|
16:0 PEG2000 PE ammonium; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG2000 ammonium (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG2000 ammonium enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG2000 ammonium helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG2000 ammonium serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
-
- HY-W441015A
-
|
|
Liposome
|
Others
|
|
DSPE-m-PEG3400-NHS is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
|
-
-
- HY-W440690
-
|
|
Liposome
|
Cancer
|
|
Cholesterol-PEG2000-amine is a pegylated lipids which can be used for preparation of liposome or nanoparticle. The lipophilic moiety can encapsulate hydrophobic drugs whereas the hydrophilic PEG chain helps the overal water solubility of the micelles.
|
-
-
- HY-W440706
-
|
|
Liposome
|
Cancer
|
|
Cholesterol-PEG2000-alcohol is a pegylated lipids which can be used for preparation of liposome or nanoparticle. The lipophilic moiety can encapsulate hydrophobic drugs whereas the hydrophilic PEG chain helps the overal water solubility of the micelles. The amine can react with an activated NHS ester to form a stable amide bond.
|
-
-
- HY-155887
-
|
DSPE-PEG-NH2, MW 3400 ammonium
|
Liposome
|
Cancer
|
|
DSPE-PEG-Amine (DSPE-PEG-NH2), MW 3400 ammonium is an amino-functionalized PEGylated phospholipid. It serves not only as a key component for preparing σ receptor-targeted liposomes (such as anisamide-modified lipids) but also as a starting material for synthesizing click chemistry- and tumor-targeted lipids including DSPE-PEG-DBCO (HY-155788) and DSPE-PEG2000-TCO (HY-170704). DSPE-PEG-Amine, MW 3400 ammonium effectively modulates the ζ potential of nanoparticles, enables complexation with nucleic acids or proteins to protect DNA from nuclease degradation, and supports ligand conjugation on the nanoparticle surface. It is used in studies related to DU-145 tumors, breast cancer, and other relevant research .
|
-
-
- HY-N15973
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSPE PEG2k-OH ammonium is a hydroxyl-terminated PEGylated phospholipid. The hydrophobic tail allows for the encapsulation and aggregation of other hydrophobic drugs, and the hydroxyl terminus is suitable for further reactions. DSPE PEG2k-OH ammonium can be used to prepare liposomes or lipid nanoparticles .
|
-
-
- HY-W591332
-
|
|
Liposome
|
Cancer
|
|
mPEG2000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the other end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications.
|
-
-
- HY-159866
-
|
mPEG2000-Cholesterol
|
Liposome
|
Others
|
|
mPEG2000-CLS (mPEG2000-Cholesterol) is a PEGylated form of Cholesterol (HY-N0322). mPEG2000-CLS can be used to prepare liposome or nanoparticle .
|
-
-
- HY-W440722
-
|
|
Liposome
|
Others
|
|
Cholesterol-PEG1000-Thiol is a PEGylated lipid that forms micelles in water and can be used to prepare liposomes or nanoparticles as drug delivery systems. The thiol moiety reacts with maleimide to form a stable thioether bond .
|
-
-
- HY-W591332A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the?other?end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-185585
-
|
|
Drug Intermediate
|
Cancer
|
|
JNJ-27548547, Mitomycin C (HY-13316) prodrug, is a Mitomycin C and lipophilic group conjugate. JNJ-27548547 undergoes thiolytic cleavage of its dithiobenzyl linker in the presence of reducing agents to release active substance Mitomycin C. JNJ-27548547 is formulated into pegylated liposomes (PL-MLP) with high antitumor activity in mice models .
|
-
-
- HY-174972I
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W440988D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG750 is a PEGylated phospholipid containing DOPE. DOPE-mPEG750 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W440988E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG10000 is a PEGylated phospholipid containing DOPE. DOPE-mPEG10000 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W440988H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG20000 is a PEGylated phospholipid containing DOPE. DOPE-mPEG20000 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W440988I
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG30000 is a PEGylated phospholipid containing DOPE. DOPE-mPEG30000 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W440988A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG350 is a PEGylated phospholipid containing DOPE. DOPE-mPEG350 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W440988B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG500 is a PEGylated phospholipid containing DOPE. DOPE-mPEG500 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W440988C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-mPEG550 is a PEGylated phospholipid containing DOPE. DOPE-mPEG550 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
-
- HY-W1052148C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DSG is a PEGylated phospholipid containing DSG. mPEG1000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DSG is a PEGylated phospholipid containing DSG. mPEG500-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1048624B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DSG is a PEGylated phospholipid containing DSG. mPEG10000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1048624A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG5000-DSG is a PEGylated phospholipid containing DSG. mPEG5000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052148B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052192B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DMPE is a PEGylated phospholipid containing DMPE. mPEG20000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1049054C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DSG is a PEGylated phospholipid containing DSG. mPEG550-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052192C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DMPE is a PEGylated phospholipid containing DMPE. mPEG30000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052148D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DMG is a PEGylated phospholipid containing DMG. mPEG1000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1048624C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DSG is a PEGylated phospholipid containing DSG. mPEG20000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DSG is a PEGylated phospholipid containing DSG. mPEG30000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972J
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DSG is a PEGylated phospholipid containing DSG. mPEG750-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052192A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DMPE is a PEGylated phospholipid containing DMPE. mPEG10000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DSG is a PEGylated phospholipid containing DSG. mPEG350-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-172723
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG2000-T7 is a PEGylated compound composed of DSPE and peptideT7. T7 (HAIYPRH) specifically binds to TfR. DSPE-PEG2000-T7 can be used to prepare T7-modified liposomes, where liposomes modified with both T7 and DA7R peptides can effectively co-deliver Doxorubicin (HY-15142A) and Vincristine (HY-N0488A) to gliomas. DSPE-PEG2000-T7 can also be used to prepare nanomodulators that mediate the co-delivery of tyrosine hydroxylase mRNA and interferon gene stimulator antagonists for synergistic intervention in Parkinson's disease .
|
-
- HY-W591424
-
|
mPEG2000-SC; mPEG2000-Succinimidyl ester
|
Biochemical Assay Reagents
|
|
m-PEG2000-NHS ester (mPEG2000-SC) is a reagent with both cell adhesion inhibition and peptide conjugation functions. The NHS ester group of m-PEG2000-NHS ester forms stable amide bonds with primary amine-containing molecules (e.g., the N-terminus of MMP-2-cleavable octapeptide) to generate mPEG-peptide intermediates for liposome surface modification. When m-PEG2000-NHS ester is immobilized on a cystamine-modified gold surface, it can construct an in vitro model for cell adhesion kinetic studies, and higher PEG density and thicker layers correlate with lower cell adhesion rates. m-PEG2000-NHS ester can synthesize MMP-2-responsive PEGylated lipid conjugates to achieve MMP-triggered dePEGylation in the tumor microenvironment. m-PEG2000-NHS ester can be used in studies related to colon cancer and other conditions .
|
-
- HY-144012
-
|
16:0 PEG2000 PE ammonium; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000 ammonium (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG2000 ammonium enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG2000 ammonium helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG2000 ammonium serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
- HY-W441015A
-
|
|
Biochemical Assay Reagents
|
|
DSPE-m-PEG3400-NHS is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
|
-
- HY-155887
-
|
DSPE-PEG-NH2, MW 3400 ammonium
|
Biochemical Assay Reagents
|
|
DSPE-PEG-Amine (DSPE-PEG-NH2), MW 3400 ammonium is an amino-functionalized PEGylated phospholipid. It serves not only as a key component for preparing σ receptor-targeted liposomes (such as anisamide-modified lipids) but also as a starting material for synthesizing click chemistry- and tumor-targeted lipids including DSPE-PEG-DBCO (HY-155788) and DSPE-PEG2000-TCO (HY-170704). DSPE-PEG-Amine, MW 3400 ammonium effectively modulates the ζ potential of nanoparticles, enables complexation with nucleic acids or proteins to protect DNA from nuclease degradation, and supports ligand conjugation on the nanoparticle surface. It is used in studies related to DU-145 tumors, breast cancer, and other relevant research .
|
-
- HY-W440722
-
|
|
Biochemical Assay Reagents
|
|
Cholesterol-PEG1000-Thiol is a PEGylated lipid that forms micelles in water and can be used to prepare liposomes or nanoparticles as drug delivery systems. The thiol moiety reacts with maleimide to form a stable thioether bond .
|
-
- HY-W591332A
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the?other?end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-174972I
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W440988D
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG750 is a PEGylated phospholipid containing DOPE. DOPE-mPEG750 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W440988E
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG10000 is a PEGylated phospholipid containing DOPE. DOPE-mPEG10000 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W440988H
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG20000 is a PEGylated phospholipid containing DOPE. DOPE-mPEG20000 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W440988I
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG30000 is a PEGylated phospholipid containing DOPE. DOPE-mPEG30000 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W440988A
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG350 is a PEGylated phospholipid containing DOPE. DOPE-mPEG350 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W440988B
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG500 is a PEGylated phospholipid containing DOPE. DOPE-mPEG500 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W440988C
-
|
|
Biochemical Assay Reagents
|
|
DOPE-mPEG550 is a PEGylated phospholipid containing DOPE. DOPE-mPEG550 combines the membrane fusion capabilities of DOPE with the stealth properties of PEG, playing a crucial role in mRNA vaccines, long-circulating liposomes, and drug delivery systems.
|
-
- HY-W1052148C
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764C
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381E
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DSG is a PEGylated phospholipid containing DSG. mPEG1000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764E
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381B
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DSG is a PEGylated phospholipid containing DSG. mPEG500-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624B
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DSG is a PEGylated phospholipid containing DSG. mPEG10000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972B
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624A
-
|
|
Biochemical Assay Reagents
|
|
mPEG5000-DSG is a PEGylated phospholipid containing DSG. mPEG5000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972D
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148B
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052192B
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DMPE is a PEGylated phospholipid containing DMPE. mPEG20000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1049054C
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381C
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DSG is a PEGylated phospholipid containing DSG. mPEG550-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052192C
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DMPE is a PEGylated phospholipid containing DMPE. mPEG30000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764D
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972C
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972H
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148D
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DMG is a PEGylated phospholipid containing DMG. mPEG1000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624C
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DSG is a PEGylated phospholipid containing DSG. mPEG20000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381H
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DSG is a PEGylated phospholipid containing DSG. mPEG30000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972E
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972J
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764B
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381D
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DSG is a PEGylated phospholipid containing DSG. mPEG750-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052192A
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DMPE is a PEGylated phospholipid containing DMPE. mPEG10000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381A
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DSG is a PEGylated phospholipid containing DSG. mPEG350-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
| Cat. No. |
상품명 |
Category |
Target |
Chemical Structure |
-
- HY-N15973
-
|
|
Lipid
|
Biochemical Assay Reagents
|
|
DSPE PEG2k-OH ammonium is a hydroxyl-terminated PEGylated phospholipid. The hydrophobic tail allows for the encapsulation and aggregation of other hydrophobic drugs, and the hydroxyl terminus is suitable for further reactions. DSPE PEG2k-OH ammonium can be used to prepare liposomes or lipid nanoparticles .
|
-
| Cat. No. |
상품명 |
|
Classification |
-
- HY-172723
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG2000-T7 is a PEGylated compound composed of DSPE and peptideT7. T7 (HAIYPRH) specifically binds to TfR. DSPE-PEG2000-T7 can be used to prepare T7-modified liposomes, where liposomes modified with both T7 and DA7R peptides can effectively co-deliver Doxorubicin (HY-15142A) and Vincristine (HY-N0488A) to gliomas. DSPE-PEG2000-T7 can also be used to prepare nanomodulators that mediate the co-delivery of tyrosine hydroxylase mRNA and interferon gene stimulator antagonists for synergistic intervention in Parkinson's disease .
|
-
- HY-W591424
-
|
mPEG2000-SC; mPEG2000-Succinimidyl ester
|
|
Polymers
|
|
m-PEG2000-NHS ester (mPEG2000-SC) is a reagent with both cell adhesion inhibition and peptide conjugation functions. The NHS ester group of m-PEG2000-NHS ester forms stable amide bonds with primary amine-containing molecules (e.g., the N-terminus of MMP-2-cleavable octapeptide) to generate mPEG-peptide intermediates for liposome surface modification. When m-PEG2000-NHS ester is immobilized on a cystamine-modified gold surface, it can construct an in vitro model for cell adhesion kinetic studies, and higher PEG density and thicker layers correlate with lower cell adhesion rates. m-PEG2000-NHS ester can synthesize MMP-2-responsive PEGylated lipid conjugates to achieve MMP-triggered dePEGylation in the tumor microenvironment. m-PEG2000-NHS ester can be used in studies related to colon cancer and other conditions .
|
-
- HY-144012
-
|
16:0 PEG2000 PE ammonium; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG2000 ammonium (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG2000 ammonium enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG2000 ammonium helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG2000 ammonium serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
- HY-W441015A
-
|
|
|
Pegylated Lipids
|
|
DSPE-m-PEG3400-NHS is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
|
-
- HY-W440690
-
|
|
|
Pegylated Lipids
|
|
Cholesterol-PEG2000-amine is a pegylated lipids which can be used for preparation of liposome or nanoparticle. The lipophilic moiety can encapsulate hydrophobic drugs whereas the hydrophilic PEG chain helps the overal water solubility of the micelles.
|
-
- HY-W440706
-
|
|
|
Pegylated Lipids
|
|
Cholesterol-PEG2000-alcohol is a pegylated lipids which can be used for preparation of liposome or nanoparticle. The lipophilic moiety can encapsulate hydrophobic drugs whereas the hydrophilic PEG chain helps the overal water solubility of the micelles. The amine can react with an activated NHS ester to form a stable amide bond.
|
-
- HY-155887
-
|
DSPE-PEG-NH2, MW 3400 ammonium
|
|
Pegylated Lipids
|
|
DSPE-PEG-Amine (DSPE-PEG-NH2), MW 3400 ammonium is an amino-functionalized PEGylated phospholipid. It serves not only as a key component for preparing σ receptor-targeted liposomes (such as anisamide-modified lipids) but also as a starting material for synthesizing click chemistry- and tumor-targeted lipids including DSPE-PEG-DBCO (HY-155788) and DSPE-PEG2000-TCO (HY-170704). DSPE-PEG-Amine, MW 3400 ammonium effectively modulates the ζ potential of nanoparticles, enables complexation with nucleic acids or proteins to protect DNA from nuclease degradation, and supports ligand conjugation on the nanoparticle surface. It is used in studies related to DU-145 tumors, breast cancer, and other relevant research .
|
-
- HY-W591332
-
|
|
|
Pegylated Lipids
|
|
mPEG2000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the other end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications.
|
-
- HY-159866
-
|
mPEG2000-Cholesterol
|
|
Pegylated Lipids
|
|
mPEG2000-CLS (mPEG2000-Cholesterol) is a PEGylated form of Cholesterol (HY-N0322). mPEG2000-CLS can be used to prepare liposome or nanoparticle .
|
-
- HY-W440722
-
|
|
|
Pegylated Lipids
|
|
Cholesterol-PEG1000-Thiol is a PEGylated lipid that forms micelles in water and can be used to prepare liposomes or nanoparticles as drug delivery systems. The thiol moiety reacts with maleimide to form a stable thioether bond .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- 상품명:
- Cat. No.:
- 수량:
- MCE Japan Authorized Agent:
